<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36031313</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">0072-9752</ISSN><JournalIssue CitedMedium="Internet"><Volume>189</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Handbook of clinical neurology</Title><ISOAbbreviation>Handb Clin Neurol</ISOAbbreviation></Journal><ArticleTitle>Neurologic complications of coronavirus and other respiratory viral infections.</ArticleTitle><Pagination><StartPage>331</StartPage><EndPage>358</EndPage><MedlinePgn>331-358</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/B978-0-323-91532-8.00004-5</ELocationID><ELocationID EIdType="pii" ValidYN="Y">B978-0-323-91532-8.00004-5</ELocationID><Abstract><AbstractText>In humans, several respiratory viruses can have neurologic implications affecting both central and peripheral nervous system. Neurologic manifestations can be linked to viral neurotropism and/or indirect effects of the infection due to endothelitis with vascular damage and ischemia, hypercoagulation state with thrombosis and hemorrhages, systemic inflammatory response, autoimmune reactions, and other damages. Among these respiratory viruses, recent and huge attention has been given to the coronaviruses, especially the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic started in 2020. Besides the common respiratory symptoms and the lung tropism of SARS-CoV-2 (COVID-19), neurologic manifestations are not rare and often present in the severe forms of the infection. The most common acute and subacute symptoms and signs include headache, fatigue, myalgia, anosmia, ageusia, sleep disturbances, whereas clinical syndromes include mainly encephalopathy, ischemic stroke, seizures, and autoimmune peripheral neuropathies. Although the pathogenetic mechanisms of COVID-19 in the various acute neurologic manifestations are partially understood, little is known about long-term consequences of the infection. These consequences concern both the so-called long-COVID (characterized by the persistence of neurological manifestations after the resolution of the acute viral phase), and the onset of new neurological symptoms that may be linked to the previous infection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cavallieri</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neurology Unit, Neuromotor and Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy; Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sellner</LastName><ForeName>Johann</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Landesklinikum Mistelbach-G&#xe4;nserndorf, Mistelbach, Austria; Department of Neurology, Christian Doppler Medical Center, Paracelsus Medical University, Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zedde</LastName><ForeName>Marialuisa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurology Unit, Neuromotor and Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moro</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Neurology, CHU of Grenoble, Grenoble Alpes University, Grenoble Institute of Neurosciences, Grenoble, France. Electronic address: emoro@chu-grenoble.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Handb Clin Neurol</MedlineTA><NlmUniqueID>0166161</NlmUniqueID><ISSNLinking>0072-9752</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="Y">Nervous System Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010523" MajorTopicYN="Y">Peripheral Nervous System Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012640" MajorTopicYN="N">Seizures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Coronavirus</Keyword><Keyword MajorTopicYN="N">Neurology</Keyword><Keyword MajorTopicYN="N">Respiratory</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Viral infection</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>28</Day><Hour>21</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36031313</ArticleId><ArticleId IdType="pmc">PMC9418023</ArticleId><ArticleId IdType="doi">10.1016/B978-0-323-91532-8.00004-5</ArticleId><ArticleId IdType="pii">B978-0-323-91532-8.00004-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abbott C.A., Baker E., Sutherland G.R., et al. Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene. Immunogenetics. 1994;40:331&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">7927537</ArticleId></ArticleIdList></Reference><Reference><Citation>Abenza-Abild&#xfa;a M.J., Ram&#xed;rez-Prieto M.T., Moreno-Zabaleta R., et al. Neurological complications in critical patients with COVID-19. Neurologia (Engl Ed) 2020;35:621&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7546232</ArticleId><ArticleId IdType="pubmed">32912745</ArticleId></ArticleIdList></Reference><Reference><Citation>Abenza Abild&#xfa;a M.J., Atienza S., Carvalho Monteiro G., et al. Encephalopathy and encephalitis during acute SARS-CoV-2 infection. Spanish Society of Neurology COVID-19 Registry. Neurologia (Engl Ed) 2021;36:127&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833484</ArticleId><ArticleId IdType="pubmed">33549369</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal P., Ray S., Madan A., et al. Neurological manifestations in 404 COVID-19 patients in Washington State. J Neurol. 2021;268:770&#x2013;772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7407444</ArticleId><ArticleId IdType="pubmed">32761507</ArticleId></ArticleIdList></Reference><Reference><Citation>Agyeman A.A., Chin K.L., Landersdorfer C.B., et al. Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis. Mayo Clin Proc. 2020;95:1621&#x2013;1631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7275152</ArticleId><ArticleId IdType="pubmed">32753137</ArticleId></ArticleIdList></Reference><Reference><Citation>Ait Wahmane S., Achbani A., Ouhaz Z., et al. The possible protective role of &#x3b1;-synuclein against the SARS-CoV-2 infections in patients with Parkinson's disease. Mov Disord. 2020;35:1293&#x2013;1294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300655</ArticleId><ArticleId IdType="pubmed">32519352</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Saiegh F., Ghosh R., Leibold A., et al. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. J Neurol Neurosurg Psychiatry. 2020;91:846&#x2013;848.</Citation><ArticleIdList><ArticleId IdType="pubmed">32354770</ArticleId></ArticleIdList></Reference><Reference><Citation>Algahtani H., Subahi A., Shirah B. Neurological complications of middle east respiratory syndrome coronavirus: a report of two cases and review of the literature. Case Rep Neurol Med. 2016;2016:3502683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4864560</ArticleId><ArticleId IdType="pubmed">27239356</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hameed F.M. Spontaneous intracranial hemorrhage in a patient with Middle East respiratory syndrome corona virus. Saudi Med J. 2017;38:196&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5329633</ArticleId><ArticleId IdType="pubmed">28133694</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hashel J.Y., Abokalawa F., Alenzi M., et al. Coronavirus disease-19 and headache; impact on pre-existing and characteristics of de novo: a cross-sectional study. J Headache Pain. 2021;22:97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8380111</ArticleId><ArticleId IdType="pubmed">34418950</ArticleId></ArticleIdList></Reference><Reference><Citation>Allali G., Marti C., Grosgurin O., et al. Dyspnea: the vanished warning symptom of COVID-19 pneumonia. J Med Virol. 2020;92:2272&#x2013;2273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7307122</ArticleId><ArticleId IdType="pubmed">32530534</ArticleId></ArticleIdList></Reference><Reference><Citation>Andalib S., Biller J., Di Napoli M., et al. Peripheral nervous system manifestations associated with COVID-19. Curr Neurol Neurosci Rep. 2021;21:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7882462</ArticleId><ArticleId IdType="pubmed">33586020</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi Y.M., Harthi A., Hussein J., et al. Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV) Infection. 2015;43:495&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4521086</ArticleId><ArticleId IdType="pubmed">25600929</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbour N., C&#xf4;t&#xe9; G., Lachance C., et al. Acute and persistent infection of human neural cell lines by human coronavirus OC43. J Virol. 1999;73:3338&#x2013;3350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC104098</ArticleId><ArticleId IdType="pubmed">10074188</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbour N., Day R., Newcombe J., et al. Neuroinvasion by human respiratory coronaviruses. J Virol. 2000;74:8913&#x2013;8921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC102086</ArticleId><ArticleId IdType="pubmed">10982334</ArticleId></ArticleIdList></Reference><Reference><Citation>Artemiadis A., Liampas A., Hadjigeorgiou L., et al. Myelopathy associated with SARS-COV-2 infection. A systematic review. Neurol Res. 2021;43:633&#x2013;641.</Citation><ArticleIdList><ArticleId IdType="pubmed">33870878</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Simani L., Shahisavandi M., et al. COVID-19, de novo seizures, and epilepsy: a systematic review. Neurol Sci. 2021;42:415&#x2013;431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7686454</ArticleId><ArticleId IdType="pubmed">33237493</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschman T., Schneider J., Greuel S., et al. Association between SARS-CoV-2 infection and immune-mediated myopathy in patients who have died. JAMA Neurol. 2021;78:948&#x2013;960.</Citation><ArticleIdList><ArticleId IdType="pubmed">34115106</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Khunti K., Nafilyan V., et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M., Khaleeq A., Ali U., et al. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11:995&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pubmed">32167747</ArticleId></ArticleIdList></Reference><Reference><Citation>Balcom E.F., Nath A., Power C. Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease. Brain. 2021;144:3576&#x2013;3588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8719840</ArticleId><ArticleId IdType="pubmed">34398188</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldini T., Asioli G.M., Romoli M., et al. Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysis. Eur J Neurol. 2021;28:3478&#x2013;3490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014715</ArticleId><ArticleId IdType="pubmed">33426733</ArticleId></ArticleIdList></Reference><Reference><Citation>Beatman E.L., Massey A., Shives K.D., et al. Alpha-synuclein expression restricts RNA viral infections in the brain. J Virol. 2015;90:2767&#x2013;2782.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4810656</ArticleId><ArticleId IdType="pubmed">26719256</ArticleId></ArticleIdList></Reference><Reference><Citation>Benameur K., Agarwal A., Auld S.C., et al. Encephalopathy and encephalitis associated with cerebrospinal fluid cytokine alterations and coronavirus disease, Atlanta, Georgia, USA, 2020. Emerg Infect Dis. 2020;26:10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454059</ArticleId><ArticleId IdType="pubmed">32487282</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhat S., Chokroverty S. Sleep disorders and COVID-19. Sleep Med. 2021 S1389-9457(21)00403-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8286239</ArticleId><ArticleId IdType="pubmed">34391672</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocci T., Bulfamante G., Campiglio L., et al. Brainstem clinical and neurophysiological involvement in COVID-19. J Neurol. 2021;268:3598&#x2013;3600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7969346</ArticleId><ArticleId IdType="pubmed">33735401</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodro M., Compta Y., S&#xe1;nchez-Valle R. Presentations and mechanisms of CNS disorders related to COVID-19. Neurol Neuroimmunol Neuroinflamm. 2020;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808129</ArticleId><ArticleId IdType="pubmed">33310765</ArticleId></ArticleIdList></Reference><Reference><Citation>Boesl F., Audebert H., Endres M., et al. A neurological outpatient clinic for patients with post-COVID-19 syndrome&#x2014;a report on the clinical presentations of the first 100 patients. Front Neurol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8481602</ArticleId><ArticleId IdType="pubmed">34603189</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohmwald K., G&#xe1;lvez N.M.S., R&#xed;os M., et al. Neurologic alterations due to respiratory virus infections. Front Cell Neurosci. 2018;12:386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6212673</ArticleId><ArticleId IdType="pubmed">30416428</ArticleId></ArticleIdList></Reference><Reference><Citation>Boing S., Randerath W.J. Chronic hypoventilation syndromes and sleep-related hypoventilation. J Thorac Dis. 2015;7:1273&#x2013;1285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4561264</ArticleId><ArticleId IdType="pubmed">26380756</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouali-Benazzouz R., Benazzouz A. Covid-19 infection and Parkinsonism: is there a link? Mov Disord. 2021;36:1737&#x2013;1743.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242862</ArticleId><ArticleId IdType="pubmed">34080714</ArticleId></ArticleIdList></Reference><Reference><Citation>Brann D.H., Tsukahara T., Weinreb C., et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. 2020;6:eabc5801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10715684</ArticleId><ArticleId IdType="pubmed">32937591</ArticleId></ArticleIdList></Reference><Reference><Citation>Brundin P., Nath A., Beckham J.D. Is COVID-19 a perfect storm for Parkinson's disease? Trends Neurosci. 2020;43:931&#x2013;933.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577682</ArticleId><ArticleId IdType="pubmed">33158605</ArticleId></ArticleIdList></Reference><Reference><Citation>Burki N.K., Lee L.Y. Mechanisms of dyspnea. Chest. 2010;138:1196&#x2013;1201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2972628</ArticleId><ArticleId IdType="pubmed">21051395</ArticleId></ArticleIdList></Reference><Reference><Citation>Butowt R., Bilinska K. SARS-CoV-2: olfaction, brain infection, and the urgent need for clinical samples allowing earlier virus detection. ACS Chem Neurosci. 2020;11:1200&#x2013;1203.</Citation><ArticleIdList><ArticleId IdType="pubmed">32283006</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E., Pozo-Rosich P. Headache as a symptom of COVID-19: narrative review of 1-year research. Curr Pain Headache Rep. 2021;25:73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8583579</ArticleId><ArticleId IdType="pubmed">34766205</ArticleId></ArticleIdList></Reference><Reference><Citation>Casez O., Willaume G., Grand S., et al. Teaching neuroimages: SARS-CoV-2-related encephalitis: MRI pattern of olfactory tract involvement. Neurology. 2021;96:e645&#x2013;e646.</Citation><ArticleIdList><ArticleId IdType="pubmed">33154083</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavallieri F., Marti A., Fasano A., et al. Prothrombotic state induced by COVID-19 infection as trigger for stroke in young patients: a dangerous association. eNeurologicalSci. 2020;20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7296339</ArticleId><ArticleId IdType="pubmed">32566772</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavallieri F., Fioravanti V., Toschi G., et al. COVID-19 and Parkinson's disease: a casual association or a possible second hit in neurodegeneration? J Neurol. 2021;3:1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8254452</ArticleId><ArticleId IdType="pubmed">34216264</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevik M., Kuppalli K., Kindrachuk J., et al. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ. 2020;371</Citation><ArticleIdList><ArticleId IdType="pubmed">33097561</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty T., Kramer C.L., Wijdicks E.F.M., et al. Dysautonomia in Guillain-Barre syndrome: prevalence, clinical spectrum, and outcomes. Neurocrit Care. 2020;32:113&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pubmed">31297663</ArticleId></ArticleIdList></Reference><Reference><Citation>Champredon D., Bancej C., Lee L., et al. Implications of the unexpected persistence of human rhinovirus/enterovirus during the COVID-19 pandemic in Canada. Influenza Other Respir Viruses. 2021;7 doi: 10.1111/irv.12930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12930</ArticleId><ArticleId IdType="pmc">PMC8652650</ArticleId><ArticleId IdType="pubmed">34747155</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan J.F., Chan K.H., Choi G.K., et al. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation. J Infect Dis. 2013;207:1743&#x2013;1752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7107374</ArticleId><ArticleId IdType="pubmed">23532101</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlton C.L., Babady E., Ginocchio C.C., et al. Practical guidance for clinical microbiology laboratories: viruses causing acute respiratory tract infections. Clin Microbiol Rev. 2018;32</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6302358</ArticleId><ArticleId IdType="pubmed">30541871</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Chen L., Deng Q., et al. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients. J Med Virol. 2020;92:833&#x2013;840.</Citation><ArticleIdList><ArticleId IdType="pubmed">32243607</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R., Wang K., Yu J., et al. The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains. Front Neurol. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7855591</ArticleId><ArticleId IdType="pubmed">33551947</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou S.H., Beghi E., Helbok R., et al. Global incidence of neurological manifestations among patients hospitalized with COVID-19. A report from the GCS-NeuroCOVID Consortium and the ENERGY Consortium. JAMA Netw Open. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8114143</ArticleId><ArticleId IdType="pubmed">33974053</ArticleId></ArticleIdList></Reference><Reference><Citation>Clementi N., Ghosh S., Santis M.D., et al. Viral respiratory pathogens and lung injury. Clin Microbiol Rev. 2021;34:e00103&#x2013;e00120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8142519</ArticleId><ArticleId IdType="pubmed">33789928</ArticleId></ArticleIdList></Reference><Reference><Citation>Codeluppi L., Venturelli F., Rossi J., et al. Facial palsy during the COVID-19 pandemic. Brain Behav. 2020;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7821573</ArticleId><ArticleId IdType="pubmed">33159420</ArticleId></ArticleIdList></Reference><Reference><Citation>Collaborators G.D. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990&#x2013;2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18:88&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6291454</ArticleId><ArticleId IdType="pubmed">30497964</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors T.J., Ravindranath T.M., Bickham K.L., et al. Airway CD8(+) T cells are associated with lung injury during infant viral respiratory tract infection. Am J Respir Cell Mol Biol. 2016;54:822&#x2013;830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4942220</ArticleId><ArticleId IdType="pubmed">26618559</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosentino G., Todisco M., Hota N., et al. Neuropathological findings from COVID-19 patients with neurological symptoms argue against a direct brain invasion of SARS-CoV-2: a critical systematic review. Eur J Neurol. 2021;28:3856&#x2013;3865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444743</ArticleId><ArticleId IdType="pubmed">34339563</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J. The mystery of the pandemic's 'happy hypoxia'. Science. 2020;368:455&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pubmed">32355007</ArticleId></ArticleIdList></Reference><Reference><Citation>Dakhama A., Lee Y.M., Gelfand E.W. Virus-induced airway dysfunction: pathogenesis and biomechanisms. Pediatr Infect Dis J. 2005;24:S159&#x2013;S169. discussion S66-67.</Citation><ArticleIdList><ArticleId IdType="pubmed">16378041</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R. Neuroimmune interactions: from the brain to the immune system and vice versa. Physiol Rev. 2018;98:477&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5866360</ArticleId><ArticleId IdType="pubmed">29351513</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta S.D., Talwar A., Lee J.T. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public Health implications. JAMA. 2020;324:2251&#x2013;2252.</Citation><ArticleIdList><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis L.E., Koster F., Cawthon A. Neurologic aspects of influenza viruses. Handb Clin Neurol. 2014;123:619&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7152431</ArticleId><ArticleId IdType="pubmed">25015508</ArticleId></ArticleIdList></Reference><Reference><Citation>De Sanctis P., Doneddu P.E., Vigan&#xf2; L., et al. Guillain-Barr&#xe9; syndrome associated with SARS-CoV-2 infection. A systematic review. Eur J Neurol. 2020;27:2361&#x2013;2370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436512</ArticleId><ArticleId IdType="pubmed">32757404</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Negro C.A., Funk G.D., Feldman J.L. Breathing matters. Nat Rev Neurosci. 2018;19:351&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6636643</ArticleId><ArticleId IdType="pubmed">29740175</ArticleId></ArticleIdList></Reference><Reference><Citation>Demartini Z., Maranha Gatto L.A., Koppe G.L., et al. Ondine's curse: myth meets reality. Sleep Med X. 2020;2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8041132</ArticleId><ArticleId IdType="pubmed">33870169</ArticleId></ArticleIdList></Reference><Reference><Citation>Desforges M., Favreau D.J., Brison E., et al. In: Neuroviral infections. RNA viruses and retroviruses. Singh S.K., Ruzek D., editors. CRC Press/Taylor and Francis; Boca Raton: 2013. Human coronaviruses. Respiratory pathogens revisited as infectious neuroinvasive, neurotropic, and neurovirulent agents; pp. 93&#x2013;121.</Citation></Reference><Reference><Citation>Desforges M., Le Coupanec A., Brison E., et al. Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans. Adv Exp Med Biol. 2014;807:75&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7121612</ArticleId><ArticleId IdType="pubmed">24619619</ArticleId></ArticleIdList></Reference><Reference><Citation>Desforges M., Le Coupanec A., Dubeau P., et al. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. 2019;12:14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7020001</ArticleId><ArticleId IdType="pubmed">31861926</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y., He L., Zhang Q., et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 2004;203:622&#x2013;630.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7167761</ArticleId><ArticleId IdType="pubmed">15141376</ArticleId></ArticleIdList></Reference><Reference><Citation>Doo F.X., Kassim G., Lefton D.R., et al. Rare presentations of COVID-19: PRES-like leukoencephalopathy and carotid thrombosis. Clin Imaging. 2021;69:94&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7365057</ArticleId><ArticleId IdType="pubmed">32707411</ArticleId></ArticleIdList></Reference><Reference><Citation>Dub&#xe9; M., Le Coupanec A., Wong A.H.M., et al. Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43. J Virol. 2018;92:e00404&#x2013;e00418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6096804</ArticleId><ArticleId IdType="pubmed">29925652</ArticleId></ArticleIdList></Reference><Reference><Citation>Ed&#xe9;n A., Kanberg N., Gostner J., et al. CSF biomarkers in patients with COVID-19 and neurologic symptoms: a case series. Neurology. 2021;96:e294&#x2013;e300.</Citation><ArticleIdList><ArticleId IdType="pubmed">33004602</ArticleId></ArticleIdList></Reference><Reference><Citation>Eliezer M., Hamel A.L., Houdart E., et al. Loss of smell in patients with COVID-19: MRI data reveal a transient edema of the olfactory clefts. Neurology. 2020;95:e3145&#x2013;e3152.</Citation><ArticleIdList><ArticleId IdType="pubmed">32917809</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkady A., Rabinstein A.A. Acute necrotizing encephalopathy and myocarditis in a young patient with COVID-19. Neurol Neuroimmunol Neuroinflamm. 2020;7</Citation></Reference><Reference><Citation>Ellul M.A., Benjamin L., Singh B., et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19:767&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Ely E.W., Shintani A., Truman B., et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004;291:1753&#x2013;1762.</Citation><ArticleIdList><ArticleId IdType="pubmed">15082703</ArticleId></ArticleIdList></Reference><Reference><Citation>Emami A., Fadakar N., Akbari A., et al. Seizure in patients with COVID-19. Neurol Sci. 2020;41:3057&#x2013;3061.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7501768</ArticleId><ArticleId IdType="pubmed">32949289</ArticleId></ArticleIdList></Reference><Reference><Citation>Esp&#xed;ndola O.M., Gomes Y.C.P., Brand&#xe3;o C.O., et al. Inflammatory cytokine patterns associated with neurological diseases in coronavirus disease 2019. Ann Neurol. 2021;89:1041&#x2013;1045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014707</ArticleId><ArticleId IdType="pubmed">33547819</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasano A., Cavallieri F., Canali E., et al. First motor seizure as presenting symptom of SARS-CoV-2 infection. Neurol Sci. 2020;41:1651&#x2013;1653.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7229435</ArticleId><ArticleId IdType="pubmed">32417987</ArticleId></ArticleIdList></Reference><Reference><Citation>Feige J., Moser T., Hauer L., et al. Clinical challenges in a 49-year-old patient with severe tick-borne myeloradiculitis despite complete active vaccination. Vaccines (Basel) 2020;8:93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7157544</ArticleId><ArticleId IdType="pubmed">32093148</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Rodr&#xed;guez-Jim&#xe9;nez J., Fuensalida-Novo S., et al. Myalgia as a symptom at hospital admission by severe acute respiratory syndrome coronavirus 2 infection is associated with persistent musculoskeletal pain as long-term post-COVID sequelae: a case-control study. Pain. 2021;162:2832&#x2013;2840.</Citation><ArticleIdList><ArticleId IdType="pubmed">33863864</ArticleId></ArticleIdList></Reference><Reference><Citation>Filosto M., Cotti Piccinelli S., Gazzina S., et al. Guillain-Barr&#xe9; syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions. J Neurol Neurosurg Psychiatry. 2021;92:751&#x2013;756.</Citation><ArticleIdList><ArticleId IdType="pubmed">33158914</ArticleId></ArticleIdList></Reference><Reference><Citation>Flerlage T., Boyd D.F., Meliopoulos V., et al. Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract. Nat Rev Microbiol. 2021;19:425&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023351</ArticleId><ArticleId IdType="pubmed">33824495</ArticleId></ArticleIdList></Reference><Reference><Citation>Follmer C. Gut microbiome imbalance and neuroinflammation: impact of COVID-19 on Parkinson's disease. Mov Disord. 2020;35:1495&#x2013;1496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461175</ArticleId><ArticleId IdType="pubmed">32822087</ArticleId></ArticleIdList></Reference><Reference><Citation>Fragkou P.C., Moschopoulos C.D., Karofylakis E., et al. Update in viral infections in the intensive care unit. Front Med (Lausanne) 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7940368</ArticleId><ArticleId IdType="pubmed">33708775</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraiman P., Godeiro Junior C., Moro E., et al. COVID-19 and cerebrovascular diseases: a systematic review and perspectives for stroke management. Front Neurol. 2020;11:574694.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7674955</ArticleId><ArticleId IdType="pubmed">33250845</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Sabadia S., Lalchan R., et al. A prospective study of neurologic disorders in hospitalized patients with COVID-19 in New York City. Neurology. 2021;96:e575&#x2013;e586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7905791</ArticleId><ArticleId IdType="pubmed">33020166</ArticleId></ArticleIdList></Reference><Reference><Citation>Galougahi M.K., Yousefi-Koma A., Bakhshayesshkaram M., et al. 18 FDG PET/CT scan reveals hypoactive orbitofrontal cortex in anosmia of COVID-19. Acad Radiol. 2020;27:1042&#x2013;1043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7196385</ArticleId><ArticleId IdType="pubmed">32386948</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Azor&#xed;n D., Sierra &#xc1;., Trigo J., et al. Frequency and phenotype of headache in covid-19: a study of 2194 patients. Sci Rep. 2021;11:14674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8290038</ArticleId><ArticleId IdType="pubmed">34282206</ArticleId></ArticleIdList></Reference><Reference><Citation>Giangaspero F., Schiavina M., Sturani C., et al. Failure of automatic control of ventilation (Ondine's curse) associated with viral encephalitis of the brainstem: a clinicopathologic study of one case. Clin Neuropathol. 1988;7:234&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pubmed">3208461</ArticleId></ArticleIdList></Reference><Reference><Citation>Giridharan V.V., Masud F., Petronilho F., et al. Infection-induced systemic inflammation is a potential driver of Alzheimer's disease progression. Front Aging Neurosci. 2019;11:122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6546917</ArticleId><ArticleId IdType="pubmed">31191296</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Study C Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4561509</ArticleId><ArticleId IdType="pubmed">26063472</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Escobar L.G., Hoffman K.L., Choi J.J., et al. Cytokine signatures of end organ injury in COVID-19. Sci Rep. 2021;11:12606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8206105</ArticleId><ArticleId IdType="pubmed">34131192</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Martinez A., Fanjul V., Ramos C., et al. Headache during SARS-CoV-2 infection as an early symptom associated with a more benign course of disease: a case-control study. Eur J Neurol. 2021;28:3426&#x2013;3436.</Citation><ArticleIdList><ArticleId IdType="pubmed">33417287</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorski S.A., Hufford M.M., Braciale T.J. Recent insights into pulmonary repair following virus-induced inflammation of the respiratory tract. Curr Opin Virol. 2012;2:233&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3378727</ArticleId><ArticleId IdType="pubmed">22608464</ArticleId></ArticleIdList></Reference><Reference><Citation>Graf J., Hartmann C.J., Lehmann H.C., et al. Meningitis gone viral: description of the echovirus wave 2013 in Germany. BMC Infect Dis. 2019;19:1010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6883514</ArticleId><ArticleId IdType="pubmed">31783807</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers". Ann Clin Transl Neurol. 2021;8:1073&#x2013;1085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J., Gong E., Zhang B., et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202:415&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2213088</ArticleId><ArticleId IdType="pubmed">16043521</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilmot A., Maldonado Slootjes S., Sellimi A., et al. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients. J Neurol. 2020;268:751&#x2013;757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391231</ArticleId><ArticleId IdType="pubmed">32734353</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L., Jin Z., Gan T.J., et al. Silent hypoxemia in patients with COVID-19 pneumonia: a review. Med Sci Monit. 2021;27</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8518510</ArticleId><ArticleId IdType="pubmed">34635632</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S., Jawanda M.K., Taneja N., et al. A systematic review of Bell's Palsy as the only major neurological manifestation in COVID-19 patients. J Clin Neurosci. 2021;90:284&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">34275565</ArticleId></ArticleIdList></Reference><Reference><Citation>Haga S., Yamamoto N., Nakai-Murakami C., et al. Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry. Proc Natl Acad Sci U S A. 2008;105:7809&#x2013;7814.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2409424</ArticleId><ArticleId IdType="pubmed">18490652</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I., Timens W., Bulthuis M.L., et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203:631&#x2013;637.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J., Shi L.X., Xie Y., et al. Analysis of factors affecting the prognosis of COVID-19 patients and viral shedding duration. Epidemiol Infect. 2020;148</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332754</ArticleId><ArticleId IdType="pubmed">32580792</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassid V.J., Schinco M.A., Tepas J.J., et al. Definitive establishment of airway control is critical for optimal outcome in lower cervical spinal cord injury. J Trauma. 2008;65:1328&#x2013;1332.</Citation><ArticleIdList><ArticleId IdType="pubmed">19077622</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez-Fern&#xe1;ndez F., Sandoval Valencia H., Barbella-Aponte R.A., et al. Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description. Brain. 2020;143:3089&#x2013;3103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454411</ArticleId><ArticleId IdType="pubmed">32645151</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271&#x2013;280.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Hok L., Rimac H., Mavri J., et al. COVID-19 infection and neurodegeneration: computational evidence for interactions between the SARS-CoV-2 spike protein and monoamine oxidase enzymes, Comput Struct. Biotechnol J. 2022;20:1254&#x2013;1263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8868002</ArticleId><ArticleId IdType="pubmed">35228857</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes C. Review: systemic inflammation and Alzheimer's disease. Neuropathol Appl Neurobiol. 2013;39:51&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">23046210</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y., Dan X., Babbar M., et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15:565&#x2013;581.</Citation><ArticleIdList><ArticleId IdType="pubmed">31501588</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J., Jolkkonen J., Zhao C. Neurotropism of SARS-CoV-2 and its neuropathological alterations: similarities with other coronaviruses. Neurosci Biobehav Rev. 2020;119:184&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7571477</ArticleId><ArticleId IdType="pubmed">33091416</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H.Y., Shah L.M., McNally J.S., et al. COVID-19-associated myelitis involving the dorsal and lateral white matter tracts: a case series and review of the literature. AJNR Am J Neuroradiol. 2021;42:1912&#x2013;1917. a.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8562746</ArticleId><ArticleId IdType="pubmed">34413066</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulswit R.J.G., Lang Y., Bakkers M.J.G., et al. Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A. Proc Natl Acad Sci U S A. 2019;116:2681&#x2013;2690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6377473</ArticleId><ArticleId IdType="pubmed">30679277</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung E.C., Chim S.S., Chan P.K., et al. Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin Chem. 2003;49:2108&#x2013;2109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108123</ArticleId><ArticleId IdType="pubmed">14633896</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang S.T., Ballout A.A., Sonti A.N., et al. EEG abnormalities and their radiographic correlates in a COVID-19 inpatient cohort. Neurol Clin Pract. 2021 doi: 10.1212/CPJ.0000000000001136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CPJ.0000000000001136</ArticleId><ArticleId IdType="pmc">PMC9491502</ArticleId><ArticleId IdType="pubmed">36157621</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola C., Anrather J., Kamel H. Effects of COVID-19 on the nervous system. Cell. 2020;183:16&#x2013;27.e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7437501</ArticleId><ArticleId IdType="pubmed">32882182</ArticleId></ArticleIdList></Reference><Reference><Citation>Ide W., Melicosta M., Trovato M.K. Acute flaccid myelitis. Phys Med Rehabil Clin N Am. 2021;32:477&#x2013;491.</Citation><ArticleIdList><ArticleId IdType="pubmed">34175008</ArticleId></ArticleIdList></Reference><Reference><Citation>Isada C.M., Miller R. Acute infectious myelopathies. Curr Opin Infect Dis. 2020;33:251&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pubmed">32332224</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam M.A., Alam S.S., Kundu S., et al. Prevalence of headache in patients with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis of 14,275 patients. Front Neurol. 2020;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7728918</ArticleId><ArticleId IdType="pubmed">33329305</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C.B., Farzan M., Chen B., et al. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022;23:3&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacomy H., Talbot P.J. Vacuolating encephalitis in mice infected by human coronavirus OC43. Virology. 2003;315:20&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7126296</ArticleId><ArticleId IdType="pubmed">14592756</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain R., Young M., Dogra S., et al. COVID-19 related neuroimaging findings: a signal of thromboembolic complications and a strong prognostic marker of poor patient outcome. J Neurol Sci. 2020;414</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236667</ArticleId><ArticleId IdType="pubmed">32447193</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalessi M., Barati M., Rohani M., et al. Frequency and outcome of olfactory impairment and sinonasal involvement in hospitalized patients with COVID-19. Neurol Sci. 2020;41:2331&#x2013;2338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7354355</ArticleId><ArticleId IdType="pubmed">32656713</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha N.K., Ojha S., Jha S.K., et al. Evidence of coronavirus (CoV) pathogenesis and emerging pathogen SARS-CoV-2 in the nervous system: a review on neurological impairments and manifestations. J Mol Neurosci. 2021;71:2192&#x2013;2209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7814864</ArticleId><ArticleId IdType="pubmed">33464535</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson D., Lynch R., Marshall C., et al. Aerosol generation by modern flush toilets. Aerosol Sci Technol. 2013;47:1047&#x2013;1057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4666014</ArticleId><ArticleId IdType="pubmed">26635429</ArticleId></ArticleIdList></Reference><Reference><Citation>Joob B., Wiwanitkit V. Neurologic syndrome due to MERS: is there a possibility that the virus can cross the blood-brain barrier to cause a neurological problem? Ann Trop Med Publ Health. 2015;8:231.</Citation></Reference><Reference><Citation>Kanberg N., Ashton N.J., Andersson L.M., et al. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. 2020;95:e1754&#x2013;e1759.</Citation><ArticleIdList><ArticleId IdType="pubmed">32546655</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimi L., Sales C., Crewther S.G., et al. Acute ischemic stroke in SARS-CoV, MERS-CoV, SARS-CoV-2: neurorehabilitation implications of inflammation induced immunological responses affecting vascular systems. Front Neurol. 2020;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7783449</ArticleId><ArticleId IdType="pubmed">33414753</ArticleId></ArticleIdList></Reference><Reference><Citation>Keddie S., Pakpoor J., Mousele C., et al. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barr&#xe9; syndrome. Brain. 2021;144:682&#x2013;693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799186</ArticleId><ArticleId IdType="pubmed">33313649</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller E., Brandi G., Winklhofer S., et al. Large and small cerebral vessel involvement in severe COVID-19: detailed clinical workup of a case series. Stroke. 2020;51:3719&#x2013;3722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7678671</ArticleId><ArticleId IdType="pubmed">33054673</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H., Spinrad A., Weiner A., et al. A unique microglia type associated with restricting development of Alzheimer's disease. Cell. 2017;169:1276&#x2013;1290.</Citation><ArticleIdList><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Keyhanian K., Umeton R.P., Mohit B., et al. SARS-CoV-2 and nervous system: from pathogenesis to clinical manifestation. J Neuroimmunol. 2020;350</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7647896</ArticleId><ArticleId IdType="pubmed">33212316</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.E., Heo J.H., Kim H.O., et al. Neurological complications during treatment of middle east respiratory syndrome. J Clin Neurol. 2017;13:227&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5532318</ArticleId><ArticleId IdType="pubmed">28748673</ArticleId></ArticleIdList></Reference><Reference><Citation>Klomp M., Ghosh S., Mohammed S., et al. From virus to inflammation, how influenza promotes lung damage. J Leukoc Biol. 2021;110:115&#x2013;122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7937770</ArticleId><ArticleId IdType="pubmed">32895987</ArticleId></ArticleIdList></Reference><Reference><Citation>Koff W.C., Williams M.A. Covid-19 and immunity in aging populations&#x2014;a new research agenda. N Engl J Med. 2020;383:804&#x2013;805.</Citation><ArticleIdList><ArticleId IdType="pubmed">32302079</ArticleId></ArticleIdList></Reference><Reference><Citation>Koralnik I.J., Tyler K.L. COVID-19: a global threat to the nervous system. Ann Neurol. 2020;88:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300753</ArticleId><ArticleId IdType="pubmed">32506549</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer S., Lersy F., Anheim M., et al. Neurologic and neuroimaging findings in patients with COVID-19: a retrospective multicenter study. Neurology. 2020;95:e1868&#x2013;e1882.</Citation><ArticleIdList><ArticleId IdType="pubmed">32680942</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota T., Gajera P.K., Kuroda N. Meta-analysis of EEG findings in patients with COVID-19. Epilepsy Behav. 2021;115</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833461</ArticleId><ArticleId IdType="pubmed">33342709</ArticleId></ArticleIdList></Reference><Reference><Citation>Labrie V., Brundin P. Alpha-synuclein to the rescue: immune cell recruitment by alpha-synuclein during gastrointestinal infection. J Innate Immun. 2017;9:437&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5607025</ArticleId><ArticleId IdType="pubmed">28866688</ArticleId></ArticleIdList></Reference><Reference><Citation>Larrosa-Barrero R., Matute W.I.G., Mutiozabal A.M., et al. Central alveolar hypoventilation due to progressive multifocal leukoencephalopathy. Pulmonology. 2018;24:54&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">29589583</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., Beckers E., et al. Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients. J Intern Med. 2021;290:451&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pubmed">33403772</ArticleId></ArticleIdList></Reference><Reference><Citation>Lempri&#xe8;re S. SARS-CoV-2 detected in olfactory neurons. Nat Rev Neurol. 2021;17:63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7781190</ArticleId><ArticleId IdType="pubmed">33398125</ArticleId></ArticleIdList></Reference><Reference><Citation>Leotard A., Levy J., Hartley S., et al. Sleep disorders in aging polio survivors: a systematic review. Ann Phys Rehabil Med. 2020;63:543&#x2013;553.</Citation><ArticleIdList><ArticleId IdType="pubmed">31794858</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerner A.M., De Rocco A.J., Yang L., et al. Unraveling the mysteries of acute flaccid myelitis: scientific opportunities and priorities for future research. Clin Infect Dis. 2021;72:2044&#x2013;2048.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8315125</ArticleId><ArticleId IdType="pubmed">32964217</ArticleId></ArticleIdList></Reference><Reference><Citation>Lersy F., Benotmane I., Helms J., et al. Cerebrospinal fluid features in patients with coronavirus disease 2019 and neurological manifestations: correlation with brain magnetic resonance imaging findings in 58 patients. J Infect Dis. 2021;223:600&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7798956</ArticleId><ArticleId IdType="pubmed">33249438</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesteberg K.E., Beckham J.D. Immunology of west Nile virus infection and the role of alpha-synuclein as a viral restriction factor. Viral Immunol. 2019;32:38&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">30222521</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung N.H.L. Transmissibility and transmission of respiratory viruses. Nat Rev Microbiol. 2021;19:528&#x2013;545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7982882</ArticleId><ArticleId IdType="pubmed">33753932</ArticleId></ArticleIdList></Reference><Reference><Citation>Leven Y., B&#xf6;sel J. Neurological manifestations of COVID-19&#x2014;an approach to categories of pathology. Neurol Res Pract. 2021;3:39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8310775</ArticleId><ArticleId IdType="pubmed">34311778</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis A., Frontera J., Placantonakis D.G., et al. Cerebrospinal fluid in COVID-19: a systematic review of the literature. J Neurol Sci. 2021;421</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833669</ArticleId><ArticleId IdType="pubmed">33561753</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis A., Frontera J., Placantonakis D.G., et al. Cerebrospinal fluid from COVID-19 patients with olfactory/gustatory dysfunction: A review. Clin Neurol Neurosurg. 2021;207</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8196517</ArticleId><ArticleId IdType="pubmed">34146842</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K., Wohlford-Lenane C., Perlman S., et al. Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J Infect Dis. 2016;213:712&#x2013;722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4747621</ArticleId><ArticleId IdType="pubmed">26486634</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S.L., Rodriguez-Ortiz C.J., Kitazawa M. Infection, systemic inflammation, and Alzheimer's disease. Microbes Infect. 2015;17:549&#x2013;556.</Citation><ArticleIdList><ArticleId IdType="pubmed">25912134</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotta E.M., Batra A., Clark J.R., et al. Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol. 2020;7:2221&#x2013;2230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7664279</ArticleId><ArticleId IdType="pubmed">33016619</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G., Beghi E. Stroke epidemiology and COVID-19 pandemic. Curr Opin Neurol. 2021;34:3&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">33278139</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Li X., Geng D., et al. Cerebral micro-structural changes in COVID-19 patients&#x2014;an MRI-based 3-month follow-up study. EClinicalMedicine. 2020;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Maas M.B. Critical medical illness and the nervous system. Continuum (Minneap Minn) 2020;26:675&#x2013;694.</Citation><ArticleIdList><ArticleId IdType="pubmed">32487902</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackie P.L. The classification of viruses infecting the respiratory tract. Paediatr Respir Rev. 2003;4:84&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7129710</ArticleId><ArticleId IdType="pubmed">12758044</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahammedi A., Saba L., Vagal A., et al. Imaging in neurological disease of hospitalized COVID-19 patients: an Italian multicenter retrospective observational study. Radiology. 2020;297:E270&#x2013;E273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7587295</ArticleId><ArticleId IdType="pubmed">32437313</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmudpour M., Roozbeh J., Keshavarz M., et al. COVID-19 cytokine storm: the anger of inflammation. Cytokine. 2020;133</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7260598</ArticleId><ArticleId IdType="pubmed">32544563</ArticleId></ArticleIdList></Reference><Reference><Citation>Manganelli F., Vargas M., Iovino A., et al. Brainstem involvement and respiratory failure in COVID-19. Neurol Sci. 2020;41:1663&#x2013;1665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7256922</ArticleId><ArticleId IdType="pubmed">32472516</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2013;690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Massey A.R., Beckham J.D. Alpha-synuclein, a novel viral restriction factor hiding in plain sight. DNA Cell Biol. 2016;35:643&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pubmed">27631132</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathys H., Davila-Velderrain J., Peng Z., et al. Single-cell transcriptomic analysis of Alzheimer's disease. Nature. 2019;570:332&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6865822</ArticleId><ArticleId IdType="pubmed">31042697</ArticleId></ArticleIdList></Reference><Reference><Citation>Maury A., Lyoubi A., Peiffer-Smadja N., et al. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: a narrative review for clinicians. Rev Neurol (Paris) 2021;177:51&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832485</ArticleId><ArticleId IdType="pubmed">33446327</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzoli M., Molinari M.A., Tondelli M., et al. Olfactory function and viral recovery in COVID-19. Brain Behav. 2020;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7994699</ArticleId><ArticleId IdType="pubmed">33465295</ArticleId></ArticleIdList></Reference><Reference><Citation>McCray P.B., Jr., Pewe L., Wohlford-Lenane C., et al. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J Virol. 2007;81:813&#x2013;821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1797474</ArticleId><ArticleId IdType="pubmed">17079315</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D., Sharif K., O'Regan A., et al. The role of cytokines including Interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020;19</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195002</ArticleId><ArticleId IdType="pubmed">32251717</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., Radke J., Dittmayer C., et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24:168&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Meskill S.D., O'Bryant S.C. Respiratory virus co-infection in acute respiratory infections in children. Curr Infect Dis Rep. 2020;22:3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7223550</ArticleId><ArticleId IdType="pubmed">31980966</ArticleId></ArticleIdList></Reference><Reference><Citation>Meunier N., Briand L., Jacquin-Piques A., et al. COVID 19-induced smell and taste impairments: putative impact on physiology. Front Physiol. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7870487</ArticleId><ArticleId IdType="pubmed">33574768</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller K.D., Schnell M.J., Rall G.F. Keeping it in check: chronic viral infection and antiviral immunity in the brain. Nat Rev Neurosci. 2016;17:766&#x2013;776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5477650</ArticleId><ArticleId IdType="pubmed">27811921</ArticleId></ArticleIdList></Reference><Reference><Citation>Montalvan V., Lee J., Bueso T., et al. Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review. Clin Neurol Neurosurg. 2020;194</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7227498</ArticleId><ArticleId IdType="pubmed">32422545</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori I., Nishiyama Y., Yokochi T., et al. Olfactory transmission of neurotropic viruses. J Neurovirol. 2005;11:129&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">16036791</ArticleId></ArticleIdList></Reference><Reference><Citation>Moro E., Priori A., Beghi E., et al. The international European Academy of Neurology survey on neurological symptoms in patients with COVID-19 infection. Eur J Neurol. 2020;27:1727&#x2013;1737.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323212</ArticleId><ArticleId IdType="pubmed">32558002</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy O.C., Messacar K., Benson L., et al. Acute flaccid myelitis: cause, diagnosis, and management. Lancet. 2021;397:334&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7909727</ArticleId><ArticleId IdType="pubmed">33357469</ArticleId></ArticleIdList></Reference><Reference><Citation>Najjar S., Najjar A., Chong D.J., et al. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation. 2020;17:231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7406702</ArticleId><ArticleId IdType="pubmed">32758257</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardone R., Versace V., Brigo F., et al. Herpes simplex virus type 2 myelitis: case report and review of the literature. Front Neurol. 2017;8:199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5423910</ArticleId><ArticleId IdType="pubmed">28539913</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence COVID-19 rapid guideline: managing the long-term effects of COVID-19. 2021. https://www.nice.org.uk/guidance/ng188 Published: 18 December 2020, Last updated: 11 November.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Netland J., Meyerholz D.K., Moore S., et al. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;82:7264&#x2013;7275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2493326</ArticleId><ArticleId IdType="pubmed">18495771</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton A.H., Cardani A., Braciale T.J. The host immune response in respiratory virus infection: balancing virus clearance and immunopathology. Semin Immunopathol. 2016;38:471&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4896975</ArticleId><ArticleId IdType="pubmed">26965109</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning P., Yang B., Yang X., et al. A nomogram to predict mechanical ventilation in Guillain-Barre syndrome patients. Acta Neurol Scand. 2020;142:466&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pubmed">32497277</ArticleId></ArticleIdList></Reference><Reference><Citation>Nogues M.A., Benarroch E. Abnormalities of respiratory control and the respiratory motor unit. Neurologist. 2008;14:273&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">18784597</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Byrne L., Webster K.E., MacKeith S., et al. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction. Cochrane Database Syst Rev. 2021;7:CD013876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8406942</ArticleId><ArticleId IdType="pubmed">34291813</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira V., Seabra M., Rodrigues R., et al. Neuro-COVID frequency and short-term outcome in the Northern Portuguese population. Eur J Neurol. 2021;28:3360&#x2013;3368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250949</ArticleId><ArticleId IdType="pubmed">33884707</ArticleId></ArticleIdList></Reference><Reference><Citation>Omrani A.S., Al-Tawfiq J.A., Memish Z.A. Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction. Rev Neurol (Paris) 2015;109:354&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4809235</ArticleId><ArticleId IdType="pubmed">26924345</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxley T.J., Mocco J., Majidi S., et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020;382:e60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7207073</ArticleId><ArticleId IdType="pubmed">32343504</ArticleId></ArticleIdList></Reference><Reference><Citation>Palaiodimou L., Stefanou M.I., Katsanos A.H., et al. Prevalence, clinical characteristics and outcomes of Guillain-Barr&#xe9; syndrome spectrum associated with COVID-19: a systematic review and meta-analysis. Eur J Neurol. 2021;28:3517&#x2013;3529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250909</ArticleId><ArticleId IdType="pubmed">33837630</ArticleId></ArticleIdList></Reference><Reference><Citation>Paniz-Mondolfi A., Bryce C., Grimes Z., et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) J Med Virol. 2020;92:699&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7264598</ArticleId><ArticleId IdType="pubmed">32314810</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavel A., Murray D.K., Stoessl A.J. COVID-19 and selective vulnerability to Parkinson's disease. Lancet Neurol. 2020;19:719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7434474</ArticleId><ArticleId IdType="pubmed">32822628</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini L., Albecka A., Mallery D.L., et al. SARS-CoV-2 infects the brain choroid plexus and disrupts the blood-CSF barrier in human brain organoids. Cell Stem Cell. 2020;27:951&#x2013;961.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7553118</ArticleId><ArticleId IdType="pubmed">33113348</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A., Odolini S., Stefano Masciocchi S., et al. Steroid-responsive encephalitis in COVID-19 disease. Ann Neurol. 2020;88:423&#x2013;427. B.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7276848</ArticleId><ArticleId IdType="pubmed">32418288</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A., Padovani A., ENCOVID-BIO Network Reply to the letter &#x201c;COVID-19-associated encephalopathy and cytokine-mediated neuroinflammation&#x201d;. Ann Neurol. 2020;88:861&#x2013;862. a.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436670</ArticleId><ArticleId IdType="pubmed">32737995</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A., Cristillo V., Cotti Piccinelli S., et al. Long-term neurological manifestations of COVID-19: prevalence and predictive factors. Neurol Sci. 2021;42:4903&#x2013;4907.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8439956</ArticleId><ArticleId IdType="pubmed">34523082</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzi M.A. Acute neurologic manifestations of respiratory viruses. Continuum (Minneap Minn) 2021;27:1365&#x2013;1381.</Citation><ArticleIdList><ArticleId IdType="pubmed">34618764</ArticleId></ArticleIdList></Reference><Reference><Citation>Politi L.S., Salsano E., Grimaldi M. Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia. JAMA Neurol. 2020;77:1028&#x2013;1029.</Citation><ArticleIdList><ArticleId IdType="pubmed">32469400</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugin D., Vargas M.I., Thieffry C., et al. COVID-19-related encephalopathy responsive to high doses glucocorticoids. Neurology. 2020;95:543&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pubmed">32680950</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xe1;bano-Su&#xe1;rez P., Bermejo-Guerrero L., M&#xe9;ndez-Guerrero A., et al. Generalized myoclonus in COVID-19. Neurology. 2020;95:e767&#x2013;e772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7455360</ArticleId><ArticleId IdType="pubmed">32439821</ArticleId></ArticleIdList></Reference><Reference><Citation>Radmanesh A., Derman A., Lui Y.W., et al. COVID-19&#x2014;associated diffuse leukoencephalopathy and microhemorrhages. Radiology. 2020;297:E223&#x2013;E227. A.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7507998</ArticleId><ArticleId IdType="pubmed">32437314</ArticleId></ArticleIdList></Reference><Reference><Citation>Radmanesh A., Raz E., Zan E., et al. Brain imaging use and findings in COVID-19: a single academic center experience in the epicenter of disease in the United States. AJNR Am J Neuroradiol. 2020;41:1179&#x2013;1183. B.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7357666</ArticleId><ArticleId IdType="pubmed">32467191</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj V.S., Mou H., Smits S.L., et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495:251&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095326</ArticleId><ArticleId IdType="pubmed">23486063</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramani A., Pranty A.I., Gopalakrishnan J. Neurotropic effects of SARS-CoV-2 modeled by the human brain organoids. Stem Cell Rep. 2021;16:373&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7879157</ArticleId><ArticleId IdType="pubmed">33631123</ArticleId></ArticleIdList></Reference><Reference><Citation>Restivo D.A., Centonze D., Alesina A., et al. Myasthenia gravis associated with SARS-CoV-2 infection. Ann Intern Med. 2020;173:1027&#x2013;1028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7429993</ArticleId><ArticleId IdType="pubmed">32776781</ArticleId></ArticleIdList></Reference><Reference><Citation>Reza-Zald&#xed;var E.E., Hern&#xe1;ndez-Sapi&#xe9;ns M.A., Minjarez B., et al. Infection mechanism of SARS-COV-2 and its implication on the nervous system. Front Immunol. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7878381</ArticleId><ArticleId IdType="pubmed">33584720</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts T.T., Leonard G.R., Cepela D.J. Classifications in brief: American Spinal Injury Association (ASIA) impairment scale. Clin Orthop Relat Res. 2017;475:1499&#x2013;1504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5384910</ArticleId><ArticleId IdType="pubmed">27815685</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodgers L., Sheppard M., Smith A., et al. Changes in seasonal respiratory illnesses in the United States during the coronavirus disease 2019 (COVID-19) pandemic. Clin Infect Dis. 2021;73:S110&#x2013;S117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8135472</ArticleId><ArticleId IdType="pubmed">33912902</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J.P., Watson C.J., Badenoch J., et al. Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives. J Neurol Neurosurg Psychiatry. 2021;92:932&#x2013;941.</Citation><ArticleIdList><ArticleId IdType="pubmed">34083395</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero J.R., Modlin J.F. In: Mandell, Douglas, and Bennett's principles and practice of infectious diseases. eighth edn. Bennett J.E., Dolin R., Martin J., editors. Elsevier; Amsterdam: 2015. Bulbar poliomyelitis; pp. 2073&#x2013;2079. e2.</Citation></Reference><Reference><Citation>Romero-S&#xe1;nchez C.M., D&#xed;az-Maroto I., Fern&#xe1;ndez-D&#xed;az E., et al. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95:e1060&#x2013;e1070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7668545</ArticleId><ArticleId IdType="pubmed">32482845</ArticleId></ArticleIdList></Reference><Reference><Citation>Romoli M., Jelcic I., Bernard-Valnet R., et al. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details. Eur J Neurol. 2020;27:1712&#x2013;1726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300895</ArticleId><ArticleId IdType="pubmed">32503088</ArticleId></ArticleIdList></Reference><Reference><Citation>Saad M., Omrani A.S., Baig K., et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis. 2014;29:301&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110769</ArticleId><ArticleId IdType="pubmed">25303830</ArticleId></ArticleIdList></Reference><Reference><Citation>Saenz Lafourcade C., Pinel Gonz&#xe1;lez A., Martin &#xc1;.G. Disimmune encephalopathy with onconeuronal antibodies in SARS-CoV-2 infected patients. Med Clin (Engl Ed) 2021;157:e357&#x2013;e358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8585633</ArticleId><ArticleId IdType="pubmed">34786483</ArticleId></ArticleIdList></Reference><Reference><Citation>Saitta L., Molin A., Villani F., et al. Brain microvascular occlusive disorder in COVID-19: a case report. Neurol Sci. 2020;41:3401&#x2013;3404.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7546130</ArticleId><ArticleId IdType="pubmed">33034804</ArticleId></ArticleIdList></Reference><Reference><Citation>Sala Frigerio C., Wolfs L., Fattorelli N., et al. The major risk factors for Alzheimer's disease: age, sex, and genes modulate the microglia response to a&#x3b2; plaques. Cell Rep. 2019;27:1293&#x2013;1306.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7340153</ArticleId><ArticleId IdType="pubmed">31018141</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos de Lima F., Issa N., Seibert K., et al. Epileptiform activity and seizures in patients with COVID-19. J Neurol Neurosurg Psychiatry. 2021;92:565&#x2013;566.</Citation><ArticleIdList><ArticleId IdType="pubmed">33158913</ArticleId></ArticleIdList></Reference><Reference><Citation>Saussez S., Sharma S., Thiriard A., et al. Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction. Eur J Neurol. 2021;28:3702&#x2013;3711.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444937</ArticleId><ArticleId IdType="pubmed">34157187</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte E.C., Hauer L., Kunz A.B., et al. Systematic review of cases of acute myelitis in individuals with COVID-19. Eur J Neurol. 2021;28:3230&#x2013;3244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8239542</ArticleId><ArticleId IdType="pubmed">34060708</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellner J., Steiner I. Neurologic complications of hepatic viruses. Handb Clin Neurol. 2014;123:647&#x2013;661.</Citation><ArticleIdList><ArticleId IdType="pubmed">25015509</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahrizaila N., Lehmann H.C., Kuwabara S. Guillain-Barre syndrome. Lancet. 2021;397:1214&#x2013;1228.</Citation><ArticleIdList><ArticleId IdType="pubmed">33647239</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang P., Zhu M., Baker M., et al. Mechanical ventilation in Guillain-Barre syndrome. Expert Rev Clin Immunol. 2020;16:1053&#x2013;1064.</Citation><ArticleIdList><ArticleId IdType="pubmed">33112177</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharifian-Dorche M., Huot P., Osherov M., et al. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic. J Neurol Sci. 2020;417</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7413162</ArticleId><ArticleId IdType="pubmed">32871412</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Z., De Vries H., Vlaar A., et al. Diaphragm pathology in critically ill patients with COVID-19 and postmortem findings from 3 medical centers. JAMA. 2020;181:122&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7670391</ArticleId><ArticleId IdType="pubmed">33196760</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Z., Bogaards S.J.P., Conijn S., et al. COVID-19 is associated with distinct myopathic features in the diaphragm of critically ill patients. BMJ Open Respir Res. 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8453595</ArticleId><ArticleId IdType="pubmed">34544735</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh B., Lant S., Cividini S., et al. Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: a systematic review and individual patient data meta-analysis. Lancet. 2021 Preprint.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9162376</ArticleId><ArticleId IdType="pubmed">35653330</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha S., Mittal S., Roy R. Parkinson's disease and the COVID-19 pandemic: a review article on the association between SARS-CoV-2 and &#x3b1;-synucleinopathy. J Mov Disord. 2021;14:184&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8490193</ArticleId><ArticleId IdType="pubmed">34315206</ArticleId></ArticleIdList></Reference><Reference><Citation>Slooter A.J.C., Otte W.M., Devlin J.W., et al. Updated nomenclature of delirium and acute encephalopathy: statement of ten Societies. Intensive Care Med. 2020;46:1020&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7210231</ArticleId><ArticleId IdType="pubmed">32055887</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith J.C., Abdala A.P., Borgmann A., et al. Brainstem respiratory networks: building blocks and microcircuits. Trends Neurosci. 2013;36:152&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4080795</ArticleId><ArticleId IdType="pubmed">23254296</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T. Neurological infection with SARS-CoV-2&#x2014;the story so far. Nat Rev Neurol. 2021;17:65&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7789883</ArticleId><ArticleId IdType="pubmed">33414554</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E., Zhang C., Israelow B., et al. A. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med. 2021;218</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Stolzenberg E., Berry D., Yang D., et al. A role for neuronal alpha-synuclein in gastrointestinal immunity. J Innate Immun. 2017;9:56&#x2013;463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5865636</ArticleId><ArticleId IdType="pubmed">28651250</ArticleId></ArticleIdList></Reference><Reference><Citation>Straburzy&#x144;ski M., Nowaczewska M., Budrewicz S., et al. COVID-19-related headache and sinonasal inflammation: a longitudinal study analysing the role of acute rhinosinusitis and ICHD-3 classification difficulties in SARS-CoV-2 infection. Cephalalgia. 2021;20 3331024211040753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8988454</ArticleId><ArticleId IdType="pubmed">34541916</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh J., Mukerji S.S., Collens S.I., et al. Skeletal muscle and peripheral nerve histopathology in COVID-19. Neurology. 2021;97:e849&#x2013;e858.</Citation><ArticleIdList><ArticleId IdType="pubmed">34099523</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgucheva I., He S., Sharma R., et al. Role of synucleins in traumatic brain injury an experimental in vitro and in vivo study. Mol Cell Neurosci. 2014;63:114&#x2013;123. B.</Citation><ArticleIdList><ArticleId IdType="pubmed">25447944</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgucheva I., Newell K.L., Burns J., et al. New &#x3b1;- and g-synuclein immunopathological lesions in human brain. Acta Neuropathologica Commun. 2014;2:132. A.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4172890</ArticleId><ArticleId IdType="pubmed">25209836</ArticleId></ArticleIdList></Reference><Reference><Citation>Surguchov A. Intracellular dynamics of synucleins: here, there and everywhere. Int Rev Cell Mol Biol. 2015;320:103&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">26614873</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan B.H., Liu J.M., Gui Y., et al. Neurological involvement in the respiratory manifestations of COVID-19 patients. Aging (Albany NY) 2021;13:4713&#x2013;4730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906194</ArticleId><ArticleId IdType="pubmed">33582654</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N., Li D., Wang X., et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844&#x2013;847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7166509</ArticleId><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>Thepmankorn P., Bach J., Lasfar A., et al. Cytokine storm induced by SARS-CoV-2 infection: the spectrum of its neurological manifestations. Cytokine. 2021;138</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832981</ArticleId><ArticleId IdType="pubmed">33360025</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirupathi S., Webb D.W., Phelan E., et al. Central hypoventilation syndrome after Haemophilus influenzae type b meningitis and herpes infection. Pediatr Neurol. 2008;39:358&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pubmed">18940561</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari S.K., Wang S., Smith D., et al. Revealing tissue-specific SARS-CoV-2 infection and host responses using human stem cell-derived lung and cerebral organoids. Stem Cell Rep. 2021;16:437&#x2013;445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7879814</ArticleId><ArticleId IdType="pubmed">33631122</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong J.Y., Wong A., Zhu D., et al. The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2020;163:3&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">32369429</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai L.K., Hsieh S.T., Chao C.C., et al. Neuromuscular disorders in severe acute respiratory syndrome. Arch Neurol. 2004;61:1669&#x2013;1673.</Citation><ArticleIdList><ArticleId IdType="pubmed">15534177</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng C.T., Huang C., Newman P., et al. Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor. J Virol. 2007;81:1162&#x2013;1173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1797529</ArticleId><ArticleId IdType="pubmed">17108019</ArticleId></ArticleIdList></Reference><Reference><Citation>Tulisiak C.T., Mercado G., Peelaerts W., et al. Can infections trigger alpha-synucleinopathies? Prog Mol Biol Transl Sci. 2019;168:299&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6857718</ArticleId><ArticleId IdType="pubmed">31699323</ArticleId></ArticleIdList></Reference><Reference><Citation>Tysnes O.B., Storstein A. Epidemiology of Parkinson's disease. J Neural Transm (Vienna) 2017;124:901&#x2013;905.</Citation><ArticleIdList><ArticleId IdType="pubmed">28150045</ArticleId></ArticleIdList></Reference><Reference><Citation>Uginet M., Breville G., Assal F., et al. COVID-19 encephalopathy: clinical and neurobiological features. J Med Virol. 2021;93:4374&#x2013;4381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251282</ArticleId><ArticleId IdType="pubmed">33782993</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Hopkins C., Petrocelli M., et al. Efficacy of corticosteroid therapy in the treatment of long-lasting olfactory disorders in COVID-19 patients. Rhinology. 2021;59:21&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">33290446</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdebenito S., Bessis S., Annane D., et al. COVID-19 lung pathogenesis in SARS-CoV-2 autopsy cases. Front Immunol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8521087</ArticleId><ArticleId IdType="pubmed">34671353</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z., Flammer A.J., Steiger P., et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417&#x2013;1418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhratsky A., Li Q., Melino S., et al. Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases? Biol Direct. 2020;15:28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7691955</ArticleId><ArticleId IdType="pubmed">33246479</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstrepen K., Baisier L., Cauwer D., et al. Neurological manifestations of COVID-19, SARS and MERS. Acta Neurol Belg. 2020;120:1051&#x2013;1060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7303437</ArticleId><ArticleId IdType="pubmed">32562214</ArticleId></ArticleIdList></Reference><Reference><Citation>Vespignani H., Colas D., Lavin B.S., et al. Report of EEG finding on critically ill patients with COVID-19. Ann Neurol. 2020;88:626&#x2013;630.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323170</ArticleId><ArticleId IdType="pubmed">32533727</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayanand P., Wilkins E., Woodhead M. Severe acute respiratory syndrome (SARS): a review. Clin Med (Lond) 2004;4:152&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4954004</ArticleId><ArticleId IdType="pubmed">15139736</ArticleId></ArticleIdList></Reference><Reference><Citation>Vohora D., Jain S., Tripathi M., et al. COVID-19 and seizures: is there a link? Epilepsia. 2020;61:1840&#x2013;1853.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537056</ArticleId><ArticleId IdType="pubmed">32944929</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakerley B.R., Yuki N. Infectious and noninfectious triggers in Guillain-Barre syndrome. Expert Rev Clin Immunol. 2013;9:627&#x2013;639.</Citation><ArticleIdList><ArticleId IdType="pubmed">23899233</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker K.A., Ficek B.N., Westbrook R. Understanding the role of systemic inflammation in Alzheimer's disease. ACS Chem Neurosci. 2019;10:3340&#x2013;3342.</Citation><ArticleIdList><ArticleId IdType="pubmed">31241312</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C.C., Prather K.A., Sznitman J., et al. Airborne transmission of respiratory viruses. Science. 2021;373:eabd9149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8721651</ArticleId><ArticleId IdType="pubmed">34446582</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen P., Wang L., Liu H., et al. Risk factors for the severity of Guillain-Barre syndrome and predictors of short-term prognosis of severe Guillain-Barre syndrome. Sci Rep. 2021;11:11578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8172857</ArticleId><ArticleId IdType="pubmed">34079013</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker A., Anson M., Harky A. Neurological manifestations of COVID-19: a systematic review and current update. Acta Neurol Scand. 2020;142:14&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7273036</ArticleId><ArticleId IdType="pubmed">32412088</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Director-general's opening remarks at the media briefing on COVID-19&#x2014;11 March 2020. 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-mediabriefing-on-covid-19%2D%2D-11-march-2020</Citation></Reference><Reference><Citation>WHO MERS situation update. October 2021. http://www.emro.who.int/health-topics/mers-cov/mers-outbreaks.html</Citation></Reference><Reference><Citation>Williams A., Branscome H., Khatkar P., et al. A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system. J Neurovirol. 2021;27:667&#x2013;690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8477646</ArticleId><ArticleId IdType="pubmed">34581996</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams S., Wynford-Thomas R., Robertson N.P. Long-COVID: neurological manifestations and management. J Neurol. 2021;268:4915&#x2013;4917.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8529360</ArticleId><ArticleId IdType="pubmed">34674007</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Xu X., Chen Z., et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7146689</ArticleId><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Zhong S., Liu J., et al. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin Infect Dis. 2005;41:1089&#x2013;1096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7107994</ArticleId><ArticleId IdType="pubmed">16163626</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Z., Yang M., Lai C.L. Long COVID-19 syndrome: a comprehensive review of its effect on various organ systems and recommendation on rehabilitation plans. Biomedicine. 2021;9:966.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394513</ArticleId><ArticleId IdType="pubmed">34440170</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Han Y., Nilsson-Payant B.E., et al. A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell Stem Cell. 2020;27:125&#x2013;136.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7303620</ArticleId><ArticleId IdType="pubmed">32579880</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang A.C., Kern F., Losada P.M., et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595:565&#x2013;571. doi: 10.1038/s41586-021-03710-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03710-0</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021;53:737&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Zhou L., Bao L., et al. SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduct Target Ther. 2021;6:337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8419672</ArticleId><ArticleId IdType="pubmed">34489403</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubair A.S., McAlpine L.S., Gardin T., et al. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020;77:1018&#x2013;1027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7484225</ArticleId><ArticleId IdType="pubmed">32469387</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>